GIST Clinical Trial - (VOYAGER) Study of Avapritinib vs Regorafenib in

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05957367` - A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies	Phase 1/Phase 2
Completed	`NCT01770405` - Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract	N/A
Active, not recruiting	`NCT03556384` - Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)	Phase 2
Recruiting	`NCT05895942` - Exploring the Molecular Mechanism Based on KIT Mutation
Completed	`NCT01459757` - Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib	N/A
Completed	`NCT00979381` - Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor	N/A
Completed	`NCT00399152` - Perifosine + Sunitinib Malate for Patients With Advanced Cancers	Phase 1
Recruiting	`NCT03715933` - Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas	Phase 1
Completed	`NCT04599660` - Study in Low Risk Gastrointestinal Stromal Tumor (GISTs)
Completed	`NCT05400018` - Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients
Recruiting	`NCT03475953` - A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors	Phase 1/Phase 2
Not yet recruiting	`NCT04825470` - Liver Transplantation for Unresectable GIST Liver Metastases	N/A
Recruiting	`NCT00687778` - 11C-Acetate PET/CT Non-FDG-Avid Tumors	N/A
Completed	`NCT00979329` - Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST	N/A
Active, not recruiting	`NCT04927260` - French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients
Completed	`NCT03880617` - Distress, Medication Adherence and Care Needs in Patients With CML and GIST Receiving Oral Targeted Therapy
Recruiting	`NCT03896958` - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Completed	`NCT01323400` - Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)	Phase 2
Recruiting	`NCT05804331` - The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Completed	`NCT01874665` - A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor	Phase 2

NCT number	NCT03465722
Study type	Interventional
Source	Blueprint Medicines Corporation
Contact
Status	Completed
Phase	Phase 3
Start date	March 26, 2018
Completion date	September 15, 2021

(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms